This dissertation describes work towards two marine alkaloid natural products of the manzamine family. The total synthesis of (–)-nakadomarin A, via two conceptually different strategies is described along with the development of a novel nitro-Mannich-Mannich cascade reaction, which has been applied in a synthesis of the diazatricyclic core of the madangamines. A short and highly stereoselective synthesis of (–)-nakadomarin A has been developed. A sequential alkyne ring-closing metathesis/syn selective reduction strategy enabled the stereoselective construction of the Z-configured alkene in the fifteen-membered macrocycle of the molecule. ‘Matched’ catalyst and substrate control facilitated a highly diastereoselective nitro olefin Michael addition to fix two of the four stereocentres in one key step. Furthermore, a nitro-Mannich/lactamization cascade, furan N-acyl iminium ion cyclisation and alkene ring-closing metathesis enabled the total synthesis of the natural product in 19 steps. In collaboration with Prof. Amir Hoveyda and Prof. Richard Schrock, an alternative approach to a highly Z-selective macrocyclic ring closure in the synthesis of (–)-nakadomarin A has been developed. Three diene substrates were prepared and the Z-selectivity of alkene ring-closing metathesis investigated using a range of molybdenum MAP (monoaryloxide pyrrolide) catalysts. Initial studies using these catalysts produced promising results (Z:E = ~1.2:1), relative to commercially available ruthenium metathesis catalysts (Z:E = 2:3). Using a recently developed chiral tungsten MAP complex, alkene ring-closing metathesis was found to proceed in excellent yield (90%) with exceptional Z:E-selectivity (Z:E ~1.2:1) and requiring only low catalyst loadings (5 mol%). A novel nitro-Mannich-Mannich cyclisation cascade has been developed allowing access to highly functionalized piperidines. Application of this unprecedented mode of reactivity using a substrate derived from a Michael-addition of methylcyanoacetate to a functionalized cyclic nitro olefin allowed the preparation of a cis-fused 6,6’-bicycle in excellent yield. Further elaboration of this 6,6’-bicycle enabled the synthesis of the diazatricyclic core of the madangamine alkaloids to be achieved.

Dendritic cells (DC) are one of the major antigen presenting cells (APC) of the body. They, by capture of antigen and cross-presentation of these antigens, activate dormant T-cells and co-activate B-cells. As such they regulate the immune system toward either a more humoral type immune response or a more cellular type immune response. These properties have made them very studied over the past decade and many works have focus on the development of vaccine or therapeutic using DCs as a target. However, most of these actual studies have been done by injection of in vitro pre-activated DCs. The major drawback of this technique is the use of non-natural and non individual specific DCs (monocytes derived DCs and/or stem cells DCs). That is why therapeutic carrier targeting specifically DCs has to be developed. To achieve this goal, specific molecules present at the surface of DCs and involved in the activation of the immune system has to be targeted. Among them, DC-Specific ICAM-3 Grabbing Non-integrin CD209 (DC-SIGN) is very specifically expressed only on one subset of DCs called interstitial DCs. This lectin has been proven to be one of the first contacts of the DCs with T-cells and to induce one major interaction for cells proliferation of dormant T-cells. The goal of the project is to design a probe that can be used in vivo and post-mortem to target DCs via DC-SIGN. Therefore, we can use these particles as a proof of concept in vivo and in vitro, record the immune response obtained with them in vivo and in vitro and design probes that can be used to induce specific immune response for future therapy development. Lewis sugars have been shown to be quite specific to DC-SIGN. Their syntheses have been carried out in our lab with a cyanomethylthio linker at their anomeric position. This linker, once activated as a 2-imino-2-methoxyethyl moiety, has permitted the attachment of the oligosaccharides at the surface of dextran-coated iron oxide MRI nanoparticle. These particles have been chosen for their powerful properties and the advantage of the technique they are used for. Indeed, as particles their sizes mimic pathogens and DCs would interact with them, as they will with pathogen. Moreover, many copies of each oligosaccharide could be attached at their surface enhancing the interaction of the particles with the targeted lectin via a multivalent effect. As a technique, MRI has the advantage to be recorded over a long period of time (compare to ¹⁸F PET for example), with a relatively low signal/noise ratio (compare to fluorescence techniques) and without being harmful. FITC fluorescent Lewis X nanoparticles have been actually design and characterised (size by DLS, number of sugar by particles by ICP or fluorescamine fluorescence assay and binding affinity by ELISA with DC-SIGN-Fc). They have been first tested in vitro with models cells (Raji and monocytes derived DCs) for specific uptake assays, where they exhibit specific uptake and internalisation. Lewis-x nanoparticles have also been tested in vivo in a rat model and have been shown to be retained in Lymph nodes compared to control particles. Post mortem analysis appears to demonstrate that these particles were internalised by rat DCs and transported in the centre of the lymph node known as the T-cell region. Finally, cytokines and CD86 concentration measurement have shown that upon internalisation of the nanoparticles, DC maturated. In addition, an antigenic OVA peptide epitope was attached to the surface of the nanoparticles for future T-cell proliferation experiments. It will allow the determination of the immune response expected. In summary, we have developed an immunogenic MRI-active probe that can target specifically DC-SIGN via the interaction with Lewis antigens present at the surface of the probe and trigger DC maturation.

This thesis details the development of manganese(III) acetate-mediated oxidative radical cyclisation methodology. In particular, the use of radicals to form complex, highly sterically congested and strained carbo- and heterocycles in a stereocontrolled manner is described. Chapter 1 gives a summary of the literature regarding three key areas relevant to this work. Radical reaction mechanisms are introduced, including the use of transition metals and lanthanides in C-centred radical cyclisations. The formation of highly sterically congested vicinal all-carbon quaternary stereocentres is also discussed. Finally, the use of radical cyclisation methodology for the synthesis of complex cyclic structures and applications in natural product total synthesis is examined. Chapter 2 gives an account of the manganese(III) acetate-mediated cyclisation of 5-pentenyl malonates bearing a terminal aryl group. The effects of the aryl group are tested with a range of electronically varied substituents. The formation of bi- and tricyclic cyclopentane-lactones bearing adjacent quaternary-quaternary-tertiary stereocentres is demonstrated. Chapter 3 demonstrates the synthesis of highly strained tricyclic bis-lactones. The metal complexes manganese(III) acetate and cerium(IV) ammonium nitrate are shown to give complementary stereoselectivity across a range of cyclisation substrates. Possible synthetic applications of tricyclic bis-lactones are also investigated. Chapter 4 details an asymmetric formal synthesis of the proteasome inhibitor salinosporamide A. An oxidative radical cyclisation forms the key heterocycle in Danishefsky’s synthesis of this biologically important molecule, and showcases the use of the radical chemistry in natural product synthesis. Full experimental details, selected NMR spectra, and X-ray crystallographic data are also provided.

This thesis describes the development of synthetic strategies towards the densely functionalised pyrrolidinone core of the polyene &beta;-lactone-&gamma;-lactam antibiotic oxazolomycin A. <strong>Chapter 1 The oxazolomycins</strong> The oxazolomycins, a unique class of biologically active molecules containing a spiro-fused β-lactone-γ-lactam ring system are introduced. The isolation, structural elucidation and biological properties of the oxazolomycins as well as those of the structurally related inthomycins are reviewed. <strong>Chapter 2 Previous syntheses</strong> The two total syntheses of neooxazolomycin and the synthetic approaches to the pyrrolidinone core of oxazolomycin A and KSM-2690 B are evaluated. <strong>Chapter 3 Project aims</strong> An outline of the synthetic strategy employed in this project and details of the novel retrosynthesis of the pyrrolidinone core of oxazolomycin A are discussed. <strong>Chapter 4 Synthetic studies towards the pyrrolidinone core of oxazolomycin A</strong> The synthetic studies carried out towards the pyrrolidinone core of oxazolomycin A are described in detail. The preparation of an advanced intermediate containing the five chiral centres, four of which are contiguous, was achieved in twenty steps as a single diastereomer and as a single enantiomer. <strong>Chapter 5 Synthetic studies towards the middle fragment of oxazolomycin A</strong> A novel synthetic approach to the diene fragment contained in oxazolomycin A is reported. The formal synthesis of a dienyl iodide, in four fewer steps than previously reported was accomplished. <strong>Chapter 6 Conclusions and future work</strong> A summary of the synthetic work reported in this thesis and proposals for future study are presented. <strong>Chapter 7 Experimental</strong> Full experimental procedures and characterisation of compounds are reported. <strong>Chapter 8 References</strong> A complete list of citations employed in the previous seven chapters is provided.

The work presented in this thesis mainly describes the development of new reactions of &beta;-lithiooxyphosphonium ylides to access stereodefined substituted alkenes in a highly convergent fashion. Firstly, &beta;-lithiooxy ylides prepared from aldehydes and phosphonium ylides were shown to react with halogen electrophiles to provide a highly stereoselective route to E-alkenyl bromides and iodides. This methodology was successfully applied to the first total synthesis of naturally occurring (5E,9Z)-6-bromohexadeca-5,9-dienoic acid. Secondly, an experimentally straightforward method was developed for the stereocontrolled formation of trisubstituted Z-allylic esters by in situ trapping of &beta;-lithiooxyphosphonium ylides with readily available halomethyl esters. The synthetic utility of this methodology was demonstrated with the synthesis of plaunotol [(2Z,6E)-2-((E)-4,8-dimethylnona-3,7-dien-1-yl)-6-methylocta-2,6-diene-1,8-diol] and the first asymmetric synthesis of the naturally occurring geranylgeraniol-derived diterpene (6S,7R,Z)-7-hydroxy-2-((E)-6-hydroxy-4-methylhex-4-enylidene)-6,10-dimethylundec-9-enyl acetate. Furthermore, the chemistry of &beta;-lithiooxyphosphonium ylides was expanded to access synthetically useful disubstituted Z-allylic esters. The synthetic utility of Z-allylic esters was also demonstrated in a versatile and diastereoselective Ireland-Claisen rearrangement to access &gamma;,&delta;-unsaturated acids. Finally, the synthesis of the side-chain of the 6,7-dideoxysqualestatin H5 was also investigated. It was demonstrated that the side-chain of 6,7-dideoxysqualestatin H5 could be accessed by a convergent and stereoselective organozinc-based strategy.

Bifunctional iminophosphoranes, containing a triaryl-substituted iminophosphorane and bis(3,5- trifluoromethyl)phenyl thiourea on a single enantiomer scaffold are novel asymmetric superbase organocatalysts reported by the Dixon group in 2014. This thesis describes our efforts to expand their scope and utility in a variety of challenging chemical transformations. Chapter 2 describes the development and application of immobilised bifunctional iminophosphorane organocatalysts. We have successfully immobilised bifunctional iminophosphoranes on a crosslinked polystyrene support and applied this sold-supported catalyst to three challenging asymmetric reactions; namely the nitro-Mannich reaction of phosphinoyl ketimines and the conjugate addition of alkylmalonates and N,N-dimethyl &beta;-keto amides to nitrostyrene. Very good yields, enantio- and diasteroselectivities were obtained in all cases. We have also demonstrated their use in a range of conjugate additions of cyclic 1,3-dicarbonyl compounds to nitroalkenes, which suffered from very slow reaction rates under tertiary amine-based bifunctional catalysis. In all cases, the immobilised bifunctional iminophosphoranes performed very well in comparison to their homogeneous counterparts. We have also demonstrated catalyst recycling over 10 cycles and application in a continuous flow system with a productivity of 7.20 mmol _producth^-1g_catalyst^-1. to the ring-opening polymerisation (ROP) of cyclic esters. We have demonstrated the performance of bifunctional iminophosphorane organocatalysts in the ROP of L-lactide (LA), δ-valerolactone (VL) and ε-caprolactone (CL). The polymerisation of LA and VL proceeded rapidly and was well controlled, while only short lengths (> 100 DP) of poly(CL) could be prepared in a controlled fashion due to hypothesised competing initiation from the catalyst. We have shown that the polymerisation of LA using our catalyst may be considered a living polymerisation. Di-block co-polymers could also be successfully prepared via sequential monomer addition or through the use of macroinitiators. We then investigated the roles of the iminophosphorane and the thiourea component of the catalyst.

Iminosugars are known to behave as carbohydrate mimics in biological systems by virtue of their similar structures. However as the ring nitrogen prevents metabolism it means that iminosugars have the potential to become inhibitors of these systems. It is known, for example, that iminosugars can behave as mimics in the hydrolysis mechanism. This leads to possible medicinal applications of iminosugars. One such case is lysosomal storage disorders which arise as a result of a genetic defect which causes missense mutations coding for the N-acetylhexosaminidase enzymatic protein. N-Acetylhexosaminidases are a sub-member of the class of glycosidase enzymes. They are responsible for the cleavage of N-acetylhexosamine residues from glycoconjugates in the lysosome. Mutations in the gene coding for this protein lead to a deficiency in the enzymatic activity resulting in accumulation of unhydrolysed substrate in the lysosome. Lysosomal storage disorders have a phenotype of poor motor development and neurological problems. The infantile form usually leads to death before the age of five. An iminosugar mimic could give rise to a possible treatment for lysosomal storage disorders by acting as a molecular chaperone during protein folding, promoting correct folding by its intrinsic affinity for the native fold of the enzyme. Likewise in the treatment of cancer, the inhibitory ability of iminosugars has potential applications. In cancer, extracellular hydrolysis occurs which favours cancer cell survival. Macrophages, which attack and eliminate cancer cells, can be activated by macrophage activating factor (MAF) which displays an α-N-acetylgalactosamine residue that appears essential for the activation cascade. Cancer cells secrete an α-N-acetylgalactosaminidase enzyme that acts to decrease the potency of MAF, thus promoting cancer cell survival. Inhibition of cancer cell α-N-acetylgalactosaminidase may restore macrophage activation and generate potential therapeutics. Chapter 1 of this thesis contains extended discussion of the aforementioned, and related, diseases and the therapeutic applications of iminosugars. Some historically and biologically important iminosugars are described along with some current iminosugar drugs. Chapter 2 describes the synthetic strategies explored in an attempt to synthesise all the members of the 2-acetamido pyrrolidine iminosugars. An overview of the compounds synthesised towards this end by a past group member is given along with the work performed as part of this thesis to complete this goal. Both enantiomers with arabino- and ribo- stereochemistry and D-lyxo- were previously synthesised. The syntheses of both enantiomers with xylo- stereochemistry along with the L-lyxo- compound were completed as part of this thesis, from either D- or L-glucuronolactone and D-ribose, respectively. Chapter 3 details the synthetic strategy adopted to synthesise the enantiomer of D-DNJNAc, the first potent α-N-acetylgalactosaminidase inhibitor to be found. The synthesis towards another piperidine iminosugar, 6-deoxy DGJNAc, is presented in the second half of this chapter, along with two related compounds.

Iminosugars are polyhydroxylated alkaloids, and can be viewed as sugar analogues in which the endocyclic oxygen atom has been replaced with nitrogen. These compounds are highly medically relevant and their biological activity is largely due to their inhibition of glycosidases. Several examples of the iminosugar class are currently marketed as drugs, and many more are in earlier stages of development for a variety of diseases and disorders. The most fruitful approaches to the chemical synthesis of iminosugars have utilised carbohydrate starting materials as optically pure chiral building blocks, or chirons. Most of the monosaccharides are not readily available, but the relatively few naturally abundant cheap sugars have been exploited as chirons for over a century. The availability of the rare sugars is growing with the development of a new biotechnological approach to their synthesis, known as Izumoring. This thesis is primarily concerned with the chemical synthesis of iminosugars from carbohydrate starting materials. The synthesis of unnaturally functionalised sugar polyols and their suitability as substrates for the Izumoring process is also discussed. Chapter 1 provides a brief general overview of the history, natural occurrence and therapeutic application of iminosugars. General strategies for their synthesis from carbohydrate chirons are discussed. Chapter 2 concerns divergent syntheses of several iminosugar targets from both enantiomers of glucuronolactone and their biological evaluation. A new scaleable synthesis of the natural product 1-deoxynojirimycin is presented that has since been adopted for commercial purposes, as well as an efficient strategy for the synthesis of both enantiomers of 2,5-dideoxy-2,5-imino- mannitol and their novel amino acid analogues. Access to hexosaminidase inhibiting acetamido- substituted piperidines is presented, including 2-acetamido-1,5-imino-1,2,5-trideoxy-D- galactitol, which has been found to be one of the few known potent and specific inhibitors of α- N-acetyl-galactosaminidase. This inhibitory profile may allow the compound’s use for further investigation of a strategy for cancer treatment. Chapter 3 concerns the synthesis of carbon branched pyrrolidines and their biological evaluation. A novel and highly potent α-glycosidase inhibitor has been discovered, synthesised by a strategy that utilises the benzhydryl ether as key protecting group. A mild method for the introduction of this protecting group has been shown to be general to a range of sterically congested and/or acid/base sensitive carbohydrate lactones. Chapter 4 concerns the synthesis of deoxygenated and fluorinated sugar alcohols and their successful biotechnological transformation into ketoses by the Izumoring process. Publications arising from this work are included in the Appendix.

This thesis firstly describes a synthesis of the natural product taurospongin A, a potent DNA polymerase beta inhibitor. Sharpless asymmetric dihydroxylation on olefin <b>E-1.60</b> followed by selective deoxygenation at C(2) via Barton‒McCombie reaction delivers the desired C(1)–C(10) carboxylic acid core. Subsequent esterification of the C(1)–C(10) fragment with C(1′)–C(25′) fatty acid furnishes the natural product in 13.5% yield. The structure of an unnamed natural product <b>2.14</b> isolated in 1974 is proven to be misassigned by previous studies within the Robertson group. As described in this thesis, two proposed structures A and B are obtained via total synthesis in order to reveal the identity of the natural product. A synthesis of key intermediate spirocycles <b>2.148</b> and <b>2.158</b> with desired trans- diol moiety is described by a dihydroxylation reaction on an electron deficient gamma-keto unsaturated acid with subsequent spirocyclisation reaction. Finally, methodology for generating high-value synthetic intermediates by an asymmetric, one-pot enzymatic di/polycarbonyl reduction is described. The concept of such methodology is first proven by the synthesis of (3R)-hydroxybutyl (3R)-hydroxybutanoate <b>3.20</b>. This thesis then describes substrate scope studies and corresponding stereochemical proof to provide more information about this methodology.

Chiral amines represent a pervasive structural motif found in various natural products, pharmaceuticals, agrochemicals and fine chemicals. Their preparation in single-enantiomer form continues to attract significant research attention and although many advances have been made in the area of synthetic organic chemistry to increase the scope of the routes to these moieties, there remains an ever-growing need of general strategies for the assembly of structurally-diverse amines which also conform to the efficiency and environmental requirements of modern manufacturing processes. This report investigates biocatalytic routes as a means for constructing chiral amine scaffolds, which offer a more environmentally benign approach when compared with traditional chemocatalysed processes. Probing the catalysts available in the biocatalytic toolbox of enzymes, several routes were examined in more detail. Imine reductases (IREDs) represent a recent addition to the toolbox, enzymes which by definition are able to reduce pre-formed imines to their corresponding amines with high selectivity. This report analyses the (R)-imine reductase [(R)-IRED] from Streptomyces sp. GF3587, one of the first imine reductases identified for its biocatalytic potential, in greater depth. The enzyme was found to catalyse the reduction of a broad range of cyclic imines while displaying high levels of activity and selectivity, thereby offering a direct route of access to chiral secondary and tertiary amines. Substrate kinetic parameters were established for the enzyme in order to understand its substrate preferences and the enzyme’s catalytic mechanism was probed through the generation of mutant (R)-IREDs. Owing to their operation under physiological conditions as well as the orthogonal nature of their reactions, it is possible to combine multiple enzyme reactions to enable cascades. This report examines a multi-enzyme reaction combining ω-transaminases (ATAs) with imine reductases, for the synthesis of chiral disubstituted piperidines from simple diketone substrates. The cascade was then taken a step further by the inclusion of the carboxylic acid reductase (CAR) enzyme, for the synthesis of the nitrogen-containing heterocycles morpholine and thiomorpholine from ketoacid compounds. Finally, the well-established deracemisation technique, employing a selective amine oxidase (AO) with either a non-selective chemical reducing agent or a biocatalytic reductant (IRED), was explored in more detail by encompassing new substrate motifs. As biocatalysis becomes more readily accepted as a general technique in the synthetic chemist’s repertoire, the concept of carrying out enzymatic reactions in constant flow was explored as a means for applying this methodology with increased production and decreased processing rates.